ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
Recruiting · NCT06498479 · Registry updated 2024-10-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 3 | 2024-10-16 | NCT06498479 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hansoh BioMedical R&D Company | 37 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 55 |
| Harbin Medical University Cancer Hospital | Harbin | China | 51 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Jilin Cancer Hospital | Changchun | China | 24 |
| Shandong Cancer Hospital | Jinan | China | 31 |
| Shanghai Pulmonary Hospital | Shanghai | China | 23 |
| Shengjing Hospital of China Medical University | Shenyang | China | 32 |
| The First Affiliate Hospital of GUANGZHOU Medical University | Guangzhou | China | 1 |
| Tongji Hospital | Wuhan | China | 5 |